| 摘要 |
FIELD: medicine. ^ SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used in treatment of diseases of eye retina. Medication is introduced into vitreal cavity of eye. Laser coagulation of retina is performed. As medication, used is ranibizumbab, which is introduced into lenticular macular canal of vitreous body in dose 0.4 mg. Laser coagulation is performed with power of laser irradiation 100-200 mW, exposure 0.1-0.2 sec, spot diameter 200-300 mcm. Number of coagulants constitutes 250-300. ^ EFFECT: method makes it possible to reduce trauma and labour-consumption due to preliminary impact of injury focus with preparation suppressing pathologic angiogenesis with further sparing laser impact on retina. ^ 1 dwg, 2 ex |
